Westfield Capital Management’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q1
Sell
-2,720,073
Closed -$274M 350
2014
Q4
$274M Sell
2,720,073
-701,357
-20% -$54.5M 1.61% 5
2014
Q3
$227M Buy
3,421,430
+186,860
+6% +$12.3M 1.39% 9
2014
Q2
$226M Buy
3,234,570
+536,335
+20% +$36.5M 1.34% 8
2014
Q1
$197M Sell
2,698,235
-5,284
-0.2% -$394K 1.18% 10
2013
Q4
$186M Buy
2,703,519
+878,385
+48% +$56.9M 1.1% 13
2013
Q3
$116M Buy
1,825,134
+233,955
+15% +$14.1M 0.74% 42
2013
Q2
$76.8M Buy
+1,591,179
New +$78.2M 0.53% 57

Westfield Capital Management's CBST Position: Q1 2015 in Review

Westfield Capital Management sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q1 2015, closing a stake of 2,720,073 shares — an estimated $274M sold.

Westfield Capital Management first reported a position in CBST in Q2 2013 and held it in 7 quarters. The position peaked at $274M in Q4 2014. 0 funds tracked by Wall St. Rank hold CBST as of Q1 2015.

  • Westfield Capital Management reported no remaining CUBIST PHARMACEUTICALS INC position as of Q1 2015 after selling out during the quarter.
  • Westfield Capital Management sold 2,720,073 CUBIST PHARMACEUTICALS INC shares in Q1 2015, an estimated $274M.
  • Westfield Capital Management first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 7 quarters.
  • Westfield Capital Management's CUBIST PHARMACEUTICALS INC position peaked at $274M in Q4 2014.
  • 0 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q1 2015.

Based on Westfield Capital Management's 13F filing for Q1 2015, filed 13 May 2015.